Phong Phu Pharmaceutical JSC (HNX:PPP)
20,000
-100 (-0.50%)
At close: Nov 3, 2026
HNX:PPP Revenue
Phong Phu Pharmaceutical JSC had revenue of 46.99B VND in the quarter ending September 30, 2026, with 44.54% growth. This brings the company's total for the last twelve months to 167.82B, up 24.33% year-over-year. In the year 2025, Phong Phu Pharmaceutical JSC had annual revenue of 139.74B with 1.59% growth. That makes Phong Phu Pharmaceutical JSC the 39,093rd largest company in the world by revenue and 578th in Vietnam.
Revenue (ttm)
167.82B
Revenue Growth
+24.33%
P/S Ratio
1.05
Revenue / Employee
802.98M
Employees
209
Market Cap
176.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 139.74B | 2.19B | 1.59% |
| Jan 1, 2025 | 137.55B | -14.62B | -9.61% |
| Jan 1, 2024 | 152.17B | 1.60B | 1.06% |
| Dec 31, 2022 | 150.57B | 17.29B | 12.97% |
| Dec 31, 2021 | 133.29B | 17.03B | 14.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 1.01T |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Pharmedic Pharmaceutical Medicinal JSC | 565.40B |
| Central Pharmaceutical Joint Stock Company No3 | 524.41B |
| Mediplantex National Pharmaceutical JSC | 434.97B |
| Vimedimex Medi-Pharma JSC | 310.29B |
| Lamdong Pharmaceutical JSC | 278.17B |
| SPM Corporation | 202.60B |